ARTICLE | Clinical News
Erbitux cetuximab regulatory update
September 22, 2008 7:00 AM UTC
The National Comprehensive Cancer Network (NCCN) added Erbitux cetuximab to the NCCN Drugs & Biologics Compendium listing for non-small cell lung cancer (NSCLC), which the Centers for Medicare and Med...